Could Nitazoxanide Be Added to Other Essential Medicines for Integrated Neglected Tropical Disease Control and Elimination?

PLoS Neglected Tropical Diseases

Volumn 8, Issue 3, 2014, Pages

  Hotez, Peter J ^a,b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b RICE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NITAZOXANIDE;

ALLERGY; ANTIMICROBIAL ACTIVITY; ARTICLE; CLINICAL TRIAL (TOPIC); CRYPTOSPORIDIOSIS; DISEASE CONTROL; DISEASE ELIMINATION; DISEASE TRANSMISSION; GASTROINTESTINAL SYMPTOM; GIARDIASIS; HEADACHE; HELMINTHIASIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHATIC FILARIASIS; MALARIA; MORBIDITY; MORTALITY; MULTICENTER STUDY (TOPIC); NEGLECTED DISEASE; ONCHOCERCIASIS; PATHOGENESIS; SCHISTOSOMIASIS; SCLERA DISEASE; TRACHOMA; TROPICAL DISEASE; TUBERCULOSIS;

ANTIPARASITIC AGENTS; COMMUNICABLE DISEASE CONTROL; DISEASE ERADICATION; HUMANS; NEGLECTED DISEASES; PARASITIC DISEASES; THIAZOLES; TROPICAL CLIMATE;

EID: 84897416752     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0002758     Document Type: Article

References (35)

1. World Health Organization (2013) Monitoring and evaluation of preventive chemotherapy. Wkly Epidemiol Rec 88: 17-24.
2. World Health Organization (2013) Rolling out and scaling up integrated preventive chemotherapy for selected neglected tropical diseases. Wkly Epidemiol Rec 88: 161-172.
3. Hotez PJ, (2013) NTDs V.2.0: "Blue marble health" - neglected tropical disease control and elimination in a shifting health policy landscape. PLOS Negl Trop Dis 7: e2570.
4. Fenwick A, Molyneux D, Nantulya V, (2005) Achieving the Millennium Development Goals. Lancet 365: 1029-1030.
5. Molyneux DH, Hotez PJ, Fenwick A, (2005) "Rapid-impact interventions": how a policy of integrated control for Africa's neglected tropical diseases could benefit the poor. PLOS Med 2: e336.
6. World Health Organization (2006) Preventive Chemotherapy in Human Helminthiases. Coordinated use of anthelminthic drugs in control interventions: a manual for health professionals and programme managers. Available: http://whqlibdoc.who.int/publications/2006/9241547103_eng.pdf. Accessed 26 December 2013.
7. Hotez PJ, Molyneux DH, Fenwick A, Ottesen E, Ehrlich Sachs S, et al. (2006) Incorporating a rapid-impact package for neglected tropical diseases with programs for HIV/AIDS, tuberculosis, and malaria. PLOS Med 3: e102.
8. Hotez PJ, Molyneux DH, Fenwick A, Kumaresan J, Sachs SE, et al. (2007) Control of neglected tropical diseases. N Engl J Med 357: 1018-1027.
9. Porco TC, Gebre T, Ayele B, House J, Keenan J, et al. (2009) Effect of mass distribution of azithromycin for trachoma control on overall mortality in Ethiopian children: a randomized trial. JAMA 302: 962-968.
10. Keiser J, Duthaler U, Utzinger J, (2010) Update on the diagnosis and treatment of food-borne trematode infections. Curr Opin Infect Dis 23: 513-520.
11. Hotez PJ, Velasquez RM, Wolf JE (2014) Neglected Tropical Skin Diseases: Their Global Elimination through Integrated Mass Drug Administration? JAMA Dermatology. In press.
12. Freeman MC, Ogden S, Jacobson J, Abbott D, Addiss DG, et al. (2013) Integration of water, sanitation, and hygiene for the prevention and control of neglected tropical diseases: a rationale for inter-sectoral collaboration. PLOS Negl Trop Dis 7: e2439.
13. Kotloff KL, Nataro JP, Blackwelder WC, Nasrin D, Farag TH, et al. (2013) Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study. Lancet 382: 209-222.
14. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, et al. (2012) Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380: 2095-2128.
15. Murray CJL, Vos T, Lozano R, Naghavi M, Flaxman AD, et al. (2012) Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380: 2197-2223.
16. Hotez PJ, Alvarado M, Basanez MG, Bolliger I, Rupert Bourne, et al. (2014) The global burden of disease study 2010: interpretation and implications for the neglected tropical diseases. PLOS Negl Trop Dis In press.
17. Aslam S, Musher DM, (2007) Nitazoxanide: clinical studies of a broad-spectrum anti-infective agent. Future Microbiol 2: 583-590.
18. The Medical Letter (2010) Drugs for Parasitic Infections. Treat Guidel Med Lett 8 (Suppl) (): e1-20 Available: http://gorgas.dom.uab.edu/syllabus/2013/03_Parasites/RxParasitesMedicalLetter.pdf. Accessed 27 February 2014.
19. Rossignol JF, Kabil SM, El-Gohary Y, Younis AM, (2007) Nitazoxanide in the treatment of amoebiasis. Trans R Soc Trop Med Hyg 101: 1025-1031.
20. Chero JC, Saito M, Bustos JA, Blanco EM, Gonzalvez G, et al. (2007) Hymenolepis nana infection: symptoms and response to nitazoxanide in field conditions. Trans R Soc Trop Med Hyg 101: 203-205.
21. Diaz E, Mondragon J, Ramirez E, Bernal R, (2003) Epidemiology and control of intestinal parasites with nitazoxanide in children in Mexico. Am J Trop Med Hyg 68: 384-385.
22. Delgado OM, Fernandez G, Silva S, Ramirez O, Romero J, et al. (2008) Preliminary evidence of nitazoxanide activity on Toxocara canis in a mouse model. Int J Antimicrobial Agents 31: 175-187.
23. Hu Y, Ellis BL, Yiu YY, Miller MM, Urban JF, et al. (2013) An extensive comparison of the effect of the anthelminthic classes on diverse nematodes. PLOS One 8: e70702.
24. Speich B, Ame SM, Ali SM, Alles R, et al. (2012) Efficacy and safety of nitazoxanide, albendazole, and nitazoxanide-albendazole against Trichuris trichiura infection: a randomized controlled trial. PLOS Negl Trop Dis 6: e1685.
25. Musher DM, Logan N, Bressler AM, Johnson DP, Rossignol JF, (2009) Nitazoxanide versus vancomycin in Clostridium difficile infection: a randomized, double-blind study. Clin Infect Dis 48: e41-6.
26. Venugopal AA, Johnson S, (2012) Current state of Clostridium difficile treatment options. Clin Infect Dis 55 (Suppl 2) (): S71-76.
27. Rossignol JF, El-Gohary M, (2006) Nitazoxanide in the treatment of viral gastroenteritis: a randomized double-blind placebo-controlled clinical trial. Aliment Pharmacol Ther 24: 1423-1430.
28. Rossignol JF, Abou Zekry M, Hussein A, Santoro MG, (2006) Effect of nitazoxanide in treating rotavirus diarrhea: a randomized, double-blind, placebo-controlled trial. Lancet 368: 124-129.
29. Rossignol JF, El-Gohary, Yehia M, (2006) Nitazoxanide in treatment of viral gastroenteris: a randomized, double-blind, placebo-controlled clinical trial. Alimentary Pharmacology & Therapeutics 24: 1423-1430.
30. Siddiq DM, Koo HL, Adachi JA, Viola GM, (2011) Norovirus gastroenteritis successfully treated with nitazoxanide. J Infection 63: 394-397.
31. Rossignol JF, Elfert A, Keeffe EB, (2010) Treatment of chronic hepatitis C using a 4-week lead-in with nitazoxanide before peginterferon plus nitazoxanide. J Clin Gastroenterol 44: 504-509.
32. Rossignol JF, Lopez-Chegne N, Julcamoro LM, Carrion ME, Bardin MC, (2012) Nitazoxanide for the empiric treatment of pediatric infectious diarrhea. Trans R Soc Trop Med Hyg 106: 167-173.
33. World Health Organization (2013) Soil-transmitted helminthiases: number of children treated in 2011. Weekly Epidemiol Rec 88: 145-152.
34. Coulibaly JT, N'gbesso YK, Knopp S, Keiser J, N'Goran EK, et al. (2012) Efficacy and safety of praziquantel in preschool-aged children in an area co-endemic for Schistosoma mansoni and S. haematobium. PLOS Negl Trop Dis 6: e1917.
35. Sicuri E, Biao P, Hutton G, Tediosi F, Menendez C, et al. (2011) Cost-effectiveness of intermittent preventive treatment of malaria in infants (IPTi) for averting anaemia in Gabon: a comparison between intention to treat and according to protocol analyses. Malar J 10: 305.